Form 4: PLAYSTUDIOS General Counsel Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
PLAYSTUDIOS General Counsel Joel Agena sold 40,000 shares of Class A Common Stock in early July 2025 under a pre-established Rule 10b5-1 trading plan.
Summary
- Joel Agena, General Counsel of PLAYSTUDIOS, Inc. (MYPS), reported sales of Class A Common Stock.
- On July 3, 2025, 20,000 shares were sold at a weighted average price of $1.30 per share, with prices ranging from $1.28 to $1.33.
- On July 7, 2025, an additional 20,000 shares were sold at a weighted average price of $1.27 per share, with prices ranging from $1.20 to $1.31.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 12, 2025, and previously disclosed in the company's Form 10-Q filed on May 9, 2025.
- Following these sales, Joel Agena beneficially owns 35,301 shares of Class A Common Stock directly.
- He also holds various derivative securities, including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 Stock Options, and 28,040 Earnout Shares.
Sentiment
Score: 5
Explanation: The document reports routine insider stock sales conducted under a pre-established 10b5-1 plan, which is a neutral event. While sales by insiders can sometimes be viewed negatively, the pre-planned nature mitigates concerns about immediate market sentiment or company performance.
Positives
- Transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating planned personal financial management rather than a reaction to immediate company performance.
Negatives
- Sales by an insider, even if pre-planned, can sometimes be perceived negatively by the market, especially when the sale prices ($1.30 and $1.27) are significantly below the earnout share targets ($12.50 and $15.00).
Future Outlook
The vesting of Performance Stock Units is contingent upon the achievement of certain pre-established performance metrics for the fiscal year ending December 31, 2025. Earnout shares are contingent on the Class A Common Stock exceeding price targets of $12.50 and $15.00 per share within a specified period ending no later than June 21, 2026.
Management Comments
- The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.
Industry Context
This Form 4 filing reflects routine insider stock transactions, common across publicly traded companies, particularly when executives manage their equity compensation through pre-arranged trading plans like Rule 10b5-1. Such plans are designed to allow insiders to sell shares without being accused of trading on material non-public information.
Stakeholder Impact
- Shareholders: May observe insider selling, but the 10b5-1 plan context suggests it is for personal financial planning rather than a negative signal about the company.
Next Steps
- Vesting of Restricted Stock Units on various dates through January 15, 2028.
- Vesting of Performance Stock Units contingent on fiscal year 2025 performance metrics.
- Potential payment of Earnout Shares if Class A Common Stock price targets are met by June 21, 2026.
Key Dates
| Date | Description |
|---|---|
| 09/01/2018 | Date Stock Options with $0.9 exercise price became exercisable. |
| 05/01/2020 | Date Stock Options with $1.01 exercise price became exercisable. |
| 02/01/2021 | Date of the Agreement and Plan of Merger for the business combination. |
| 01/01/2023 | Date Stock Options with $1.44 exercise price became exercisable. |
| 03/11/2024 | Date 358,335 unvested Restricted Stock Units were granted to the Reporting Person. |
| 05/15/2024 | Vesting date for 66,667 Restricted Stock Units. |
| 03/07/2025 | Date 166,667 unvested Restricted Stock Units were granted to the Reporting Person. |
| 03/12/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 05/09/2025 | Date Issuer's Quarterly Report on Form 10-Q was filed, disclosing the 10b5-1 plan. |
| 05/15/2025 | Vesting date for 125,000 Restricted Stock Units (from 2024 grant) and 41,667 Restricted Stock Units (from 2025 grant). |
| 07/03/2025 | Date of sale of 20,000 Class A Common Stock. |
| 07/07/2025 | Date of sale of 20,000 Class A Common Stock. |
| 07/08/2025 | Signature date of the reporting person for the Form 4 filing. |
| 09/01/2025 | Expiration date for Stock Options with $0.9 exercise price. |
| 12/31/2025 | Fiscal year end for which Performance Stock Units vesting is contingent on achievement of performance metrics. |
| 01/15/2026 | Vesting date for 41,667 Restricted Stock Units (from 2025 grant). |
| 05/15/2026 | Vesting date for 83,334 Restricted Stock Units (from 2024 grant). |
| 06/21/2026 | Latest date for earnout shares to be paid based on price targets (five-year anniversary of the Closing of the business combination). |
| 01/15/2027 | Vesting date for 41,667 Restricted Stock Units (from 2025 grant). |
| 05/01/2027 | Expiration date for Stock Options with $1.01 exercise price. |
| 05/15/2027 | Vesting date for 83,334 Restricted Stock Units (from 2024 grant). |
| 01/15/2028 | Vesting date for 41,666 Restricted Stock Units (from 2025 grant). |
| 01/01/2029 | Expiration date for Stock Options with $1.44 exercise price. |
Recommendation
holdKeywords
PLAYSTUDIOS, MYPS, SEC Form 4, Insider Trading, Stock Sale, Joel Agena, General Counsel, Rule 10b5-1, Equity Compensation, Restricted Stock Units, Performance Stock Units, Stock Options, Earnout Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.